Sort
25,944 grants matching “neurodegeneration”
Training in Neurostatistics and Neuroepidemiology
$221,138Rebecca A. Betensky · Harvard School Of Public Health · T32 · FY2007 · NS
Modeling and analysis of the mechanochemical processes that govern clathrin-mediated endocytosis
$221,081Padmini Rangamani · University Of California, San Diego · R01 · FY2024 · GM
Project 4: Amyloid and Tau Mediated Alterations in Memory Function and Cognitive Decline
$220,943Reisa A. Sperling · Massachusetts General Hospital · P01 · FY2018 · AG
Training in Neurostatistics and Neuroepidemiology
$220,918Rebecca A. Betensky · Harvard School Of Public Health · T32 · FY2006 · NS
CATECHOL THIOETHERS IN PARKINSON'S DISEASE
$220,874University Of Washington · R01 · FY2002 · ES
Therapeutic Agonist of CX3CR1 for Alzheimer's Disease
$220,859Kevin Ron Nash · University Of South Florida · R21 · FY2019 · AG
Evaluation of Brain and Cognitive Changes in Older Adults with MCI Taking Lithium to Prevent Alzheimer Type Dementia
$220,815Ariel Gerard Gildengers · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AG
NEUROPROTECTION IN NEURODEGENERATIVE DISEASE
$220,812Mcgill University · R01 · FY2000 · NS
MALDI imaging of glial scar-forming glycans in Alzheimers disease
$220,625Kimberly Michele Alonge · University Of Washington · R21 · FY2022 · AG
CRCNS: The diffusional complexity of the brain's extracellular space
$220,597Fidel Santamaria · University Of Texas San Antonio · R01 · FY2023 · NS
CYANIDE NEUROTOXICITY--NECROTIC AND APOPTOTIC CELL DEATH
$220,593Purdue University West Lafayette · R01 · FY2001 · ES
Are the suppressors of cytokine signaling involved in Alzheimer's disease?
$220,575Douglas G Walker · Banner Sun Health Research Institute · R21 · FY2010 · AG
Parkin and MGRN1: common roles in mitochondria and neurodegeneration?
$220,500Teresa M Gunn · Mc Laughlin Research Institute · R21 · FY2011 · NS
Gene therapy for dominant neurodegenerative diseases
$220,500University Of Iowa · R01 · FY2002 · HD
Pathogenic role of the novel mitochondrial apoptotic protein PSAP in ALS
$220,500Mei-Zhen Cui · University Of Tennessee Knoxville · R21 · FY2016 · NS
Small molecule inhibitors of hyperphosphorylated tau aggregation and cytotoxicity for the development of Alzheimerâs therapeutics
$220,488Jessica Fortin · Purdue University · R21 · FY2021 · AG
Therapeutic amyloid fibrils
$220,449Jonathan B. Rothbard · Cardinal Therapeutics, Inc. · R43 · FY2014 · AI
POSTNATAL DEVELOPMENT OF VULNERABILITY TO BRAIN INJURY
$220,443University Of Chicago · R01 · FY2002 · NS
A novel neuroprotective strategy
$220,369Elias Aizenman · University Of Pittsburgh At Pittsburgh · R21 · FY2012 · NS
Structure and Function of Neuronal Calcium Binding Proteins (CaBPs)
$220,292James B Ames · University Of California At Davis · R01 · FY2011 · NS
Identification of Small Molecule Ligands with NGF Potentiating Activity
$220,272Gordon C Ibeanu · North Carolina Central University · SC3 · FY2009 · GM
Parkin mediated Neural Dysfunction in Drosophila
$220,267University Of Washington · R01 · FY2002 · NS
The role of ketones in the anticonvulsant mechanism of the ketogenic diet
$220,267James Stoll · Texas Tech University Health Scis Center · R15 · FY2009 · NS
Identification of MicroRNA and Proteomics in immune cells and plasma in ALS
$220,238Oleg Butovsky · Brigham And Women'S Hospital · R21 · FY2018 · NS
Brain oxygen consumption as an MRI biomarker of neurodegeneration in a model of Alzheimer?s disease
$220,234Hanzhang Lu · Johns Hopkins University · R21 · FY2018 · AG